Dates and Times
End Date: 6/15/2021
ObjectivesAs a result of this educational activity, webcast participants will be able to: PROVIDE basic determination if a patient may respond to calcium channel blockers for treatment of pulmonary hypertension; DETERMINE when a patient should be started on parental prostacyclins; DISCUSS the hemodynamic definition, classification and epidemiology of pulmonary arterial hypertension; and REVIEW the signs and symptoms of pulmonary arterial hypertension as well as the diagnostic algorithm.
The Center for Continuing Medical Education (CCME) at The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians
The Center for Continuing Medical Education (CCME) at The Ohio State University designates this webcasts for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Maintenance of Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.